Literature DB >> 10393362

Paracrine effects of IL-4 transfection on TS/A adenocarcinoma cells mediate reduced in vivo growth.

S Pacor1, R Gagliardi, P Spessotto, G Zabucchi, G Sava.   

Abstract

The in vitro/in vivo growth capacity and phenotype of TS/A and the IL4-transfected TS/A-IL4 cell lines were studied by cell cycle analysis, expression of ICAM-1/CD54, transferrin receptor/CD71 and E-cadherin and by histology of the primary tumors. TS/A-IL4, unlike the TS/A line, shows in vitro a marked increase in the fibroblastoid cell type and a decreased E-cadherin expression. Administration of conditioned medium containing IL4 obtained from the TS/A-IL4 cell line, stimulates CD54 expression in the TS/A cell line. TS/A-IL4 tumors grow more slowly in vivo and are ultimately rejected. These processes are accompanied by a marked increase in collagen and extracellular matrix proteins and increased recruitment and degranulation of mast cells. The paracrine effect of IL4, released by the transfected tumor cells, might be responsible for the reduced in vivo growth of the TS/A cell line in the presence of TS/A-IL4 cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393362     DOI: 10.1053/paor.1999.0172

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  25 in total

1.  Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4.

Authors:  A E Postlethwaite; M A Holness; H Katai; R Raghow
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 2.  Immunotherapy I: Cyclosine gene transfer strategies.

Authors:  M P Colombo; G Forni
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

3.  Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors.

Authors:  G Noffz; Z Qin; M Kopf; T Blankenstein
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

4.  An eosinophil-dependent mechanism for the antitumor effect of interleukin-4.

Authors:  R I Tepper; R L Coffman; P Leder
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

Review 5.  The effects of cytokine gene transfer into tumors on host cell infiltration and regression.

Authors:  W H McBride; J S Economou; R G Syljuåsen; C Parrish; D Hackman; V Latham; C S Chiang; G J Dougherty
Journal:  Anticancer Res       Date:  1996 May-Jun       Impact factor: 2.480

6.  Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma.

Authors:  A M Tiggelman; W Boers; C Linthorst; M Sala; R A Chamuleau
Journal:  J Hepatol       Date:  1995-09       Impact factor: 25.083

7.  Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells.

Authors:  Y W Huang; J A Richardson; E S Vitetta
Journal:  Cancer Res       Date:  1995-02-01       Impact factor: 12.701

8.  An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.

Authors:  F Pericle; M Giovarelli; M P Colombo; G Ferrari; P Musiani; A Modesti; F Cavallo; F Di Pierro; F Novelli; G Forni
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

9.  Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological types.

Authors:  C Schardt; J Heymanns; C Schardt; M Rotsch; K Havemann
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

10.  Expression of cell adhesion molecules in an established and characterized new human renal cell cancer line, CCF-RC7.

Authors:  F Steinbach; J Alexander; K Tanabe; R Troy; M G Edinger; R R Tubbs; J T McMahon; A C Novick; E A Klein
Journal:  Urol Res       Date:  1995
View more
  1 in total

1.  Evolutionary divergence and functions of the human interleukin (IL) gene family.

Authors:  Chad Brocker; David Thompson; Akiko Matsumoto; Daniel W Nebert; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2010-10       Impact factor: 4.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.